Training future leaders in cancer research and treatment
VOLT (Vanderbilt Oncology Training Program)
The Vanderbilt Oncology Training Program (VOLT) is designed to help future cancer doctors and researchers gain important skills and hands-on experience in treating cancer, so they can make a real difference in the field.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10915394 on NIH RePORTER |
What this research studies
The Vanderbilt Oncology Training Program (VOLT) aims to prepare hematology and oncology fellows and other trainees for impactful careers in cancer-related research. This program provides advanced training experiences, focusing on essential skills such as communication, resiliency, and team building. Trainees engage in mentored clinical research across various oncology disciplines, including molecular oncology and immunotherapy, while also receiving education on diversity and community engagement. Regular mentorship and structured progress assessments ensure that participants develop the necessary skills for a successful career in oncology.
Who could benefit from this research
Good fit: Ideal candidates for this program include hematology and oncology fellows and trainees interested in pursuing a career in cancer research.
Not a fit: Patients who are not involved in training or research roles in oncology may not directly benefit from this program.
Why it matters
Potential benefit: If successful, this program could lead to a new generation of skilled researchers who will advance cancer treatment and improve patient outcomes.
How similar studies have performed: Similar training programs have successfully produced impactful researchers in oncology, indicating a strong potential for success in this initiative.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Johnson, Douglas B — Vanderbilt University Medical Center
- Study coordinator: Johnson, Douglas B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.